Intezyne, of Tampa, Fla., received a number of patents related to its IVECT method: U.S. Patent No...Metabolon Inc., of Research Triangle Park, N.C., was awarded U.S. Patent No...NexBio Inc., of San Diego, received U.S. Patent No

Allos Therapeutics Inc., of Westminster, Colo., received U.S. Patent No...AvidBiotics Corp., of South San Francisco, was issued U.S. Patent No...HanAll Pharmaceuticals, of Seoul, South Korea, received U.S. Patent No

Champions Biotechnology Inc., of Baltimore, was granted U.S. Patent No...Endocyte Inc., of West Lafayette, Ind., received U.S. Patent No...GeneNews Ltd., of Toronto, was granted U.S. Patent No

AVEO Pharmaceuticals Inc., of Cambridge, Mass., was issued U.S. Patent No...Falcon Genomics Inc., of Pittsburgh, received U.S. Patent No

AVI BioPharma Inc., of Portland, Ore., received U.S. Patent Nos...Avigen Inc., of Alameda, Calif., was granted U.S. Patent No...Concert Pharmaceuticals Inc., of Lexington, Mass., received U.S. Patent Nos

Stromedix Inc., of Cambridge, Mass., received U.S. Patent No...VIA Pharmaceuticals Inc., of San Francisco, received U.S. Patent No...Viralytics Ltd., of Sydney, Australia, was granted U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent No...Orexigen Therapeutics Inc., of San Diego, was issued its "Weber/Cowley methods patent" (U.S. Patent No. 7,462,626), which covers methods of treating obesity with combinations of bupropion and naltrexone, the two active agents in Orexigen's lead drug, Contrave...Vical Inc., of San Diego, was issued U.S. Patent No

BioSante Pharmaceuticals Inc., of Lincolnshire, Ill., said its licensor Antares Pharma Inc., of Ewing, N.J., was issued U.S. Patent No...GeneNews Ltd., of Toronto, was granted U.S. Patent No

AVI BioPharma Inc., of Portland, Ore., received U.S. Patent No...Probiodrug AG, of Halle, Germany, received U.S. Patent No...ScinoPharm, of Tainan, Taiwan, was granted U.S. Patent No

MorphoSys Ag, of Martinsried, Germany, received U.S. Patent No...Nabi Biopharmaceuticals, of Rockville, Md., received U.S. Patent No...Peregrine Pharmaceuticals Inc., of Tustin, Calif., received U.S. Patent No

Alexion Pharmaceuticals Inc., of Cheshire, Conn., was granted U.S. Patent No...Banyan Biomarkers Inc., of Alachua, Fla., was granted U.S. Patent No

Oncolytics Biotech Inc., of Calgary, Alberta, was granted U.S. Patent No...Oncothyreon Inc., of Bellevue, Wash., received U.S. Patent No...Vermillion Inc., of Fremont, Calif., received U.S. Patent No

Genta Inc., of Berkeley Heights, N.J., was issued U.S. Patent No...Idera Pharmaceuticals Inc., of Cambridge, Mass., received U.S. Patent Nos...Jivan Biologics Inc., of Berkeley, Calif., was awarded U.S. Patent No

Bioheart Inc., of Sunrise, Fla., was awarded U.S. Patent No...Biosearch Technologies Inc., of Novato, Calif., received U.S. Patent No...Elixir Pharmaceuticals Inc., of Cambridge, Mass., received U.S. Patent No

CombinatoRx Inc., of Cambridge, Mass., was granted U.S. Patent No...Geneart AG, of Regensburg, Germany, received U.S. Patent Nos...VisiGen Biotechnologies Inc., of Houston, received U.S. Patent No

Theratechnologies Inc., of Montreal, received U.S. Patent No...Vermillion Inc., of Fremont, Calif., received U.S. Patent No...Xencor Inc., of Monrovia, Calif., received U.S. Patent No

Morphotek Inc., of Exton, Pa., received U.S. Patent No...RE39,816 (a reissue of U.S. Patent No. 6,461,828, titled "Conjunctive Analysis of Biological Marker Expression For Predicting Cardiac Mortality.") It relates to the combined use of a cardiac marker of cell injury with a marker of organ adaptation for prognosis of chronic congestive heart failure...Proteologics Inc., of Rehovot, Israel, received U.S. Patent No

Nventa Biopharmaceuticals Corp., of San Diego, was issued U.S. Patent No...Penwest Pharmaceuticals Co., of Danbury, Conn., received U.S. Patent No...Protox Therapeutics Inc., of Vancouver, British Columbia, received U.S. Patent No

Epigenomics AG, of Berlin, was issued U.S. Patent No...Idera Pharmaceuticals Inc., of Cambridge, Mass., was issued U.S. Patent No...Nanogen Inc., of San Diego, was granted U.S. Patent No